Researchers used screening tests for candidate drugs targeting cabazitaxel (CBZ)-resistant-related gene expression and identified pimozide as a potential candidate for overcoming CBZ resistance in castration-resistant prostate cancer.
[Prostate Cancer and Prostatic Diseases]
6445218 {6445218:AAAAAAAA} 1 apa 50 default 1 167376 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/